Chemical Products
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Isothiazolinone
Patient Information Cl+ Me– Isothiazolinone Your TRUE TEST ® indicates that you have a contact allergy to Cl+ Me– Isothiazolinone. Cl+ Me– Isothiazolinone in contact with your skin may result in dermatitis. Brief or occasional contact may not pose a problem. Cl+ Me– Isothiazolinone (Kathon CG ®) is a preservative with a broad spectrum of application, and is effective against bacteria, fungi, yeast and algae. Where is Cl+ Me– Isothiazolinone found? Cl+ Me– Isothiazolinone is found in many cosmetics and toiletries such as moisturizers, foundations, powders, self-tanners, sunscreens, makeup removers, eye shadows, mascaras, shampoos, liquid soaps, hair conditioners, gels, baby wipes, some toilet papers etc. It is found in topical medicines, detergents, fabric softeners, cleansers, pesticides and polishes. Industrially Cl+ Me- Isothiazolinone is used as a preservative in waterbased metalworking fluids, water-cooling and slime control agents in paper mills. It may be found in water based paints/lacquers, cleaning agents, printing inks, coloring agents, curing agents, adhesives and glues, impregnating agents and radiography liquids. If you are very sensitive you may react to airborne Cl+ Me- Isothiazolinone released from newly painted rooms where water based paints have been used. 2012 ©SmartPractice Denmark Page 1 of 2 How to avoid Cl+ Me– Isothiazolinone It is important to use only ingredient-labeled cosmetics and other skin care products that do not list Cl+ Me– Isothiazolinone or any of its synonyms on the label. Avoid exposure to chemicals containing Cl+ Me- Isothiazolinone such as water based surface coatings. If you suspect that you are being exposed to this allergen at work, consult your employer regarding Material Safety Data Sheets. -
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
Project No. TREN-05-FP6TR-S07.61320-518404-DRUID DRUID Driving under the Influence of Drugs, Alcohol and Medicines Integrated Project 1.6. Sustainable Development, Global Change and Ecosystem 1.6.2: Sustainable Surface Transport 6th Framework Programme Deliverable 4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Due date of deliverable: 21.07.2011 Actual submission date: 21.07.2011 Revision date: 21.07.2011 Start date of project: 15.10.2006 Duration: 48 months Organisation name of lead contractor for this deliverable: UVA Revision 0.0 Project co-funded by the European Commission within the Sixth Framework Programme (2002-2006) Dissemination Level PU Public PP Restricted to other programme participants (including the Commission x Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services) DRUID 6th Framework Programme Deliverable D.4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Page 1 of 243 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Authors Trinidad Gómez-Talegón, Inmaculada Fierro, M. Carmen Del Río, F. Javier Álvarez (UVa, University of Valladolid, Spain) Partners - Silvia Ravera, Susana Monteiro, Han de Gier (RUGPha, University of Groningen, the Netherlands) - Gertrude Van der Linden, Sara-Ann Legrand, Kristof Pil, Alain Verstraete (UGent, Ghent University, Belgium) - Michel Mallaret, Charles Mercier-Guyon, Isabelle Mercier-Guyon (UGren, University of Grenoble, Centre Regional de Pharmacovigilance, France) - Katerina Touliou (CERT-HIT, Centre for Research and Technology Hellas, Greece) - Michael Hei βing (BASt, Bundesanstalt für Straßenwesen, Germany). -
Mosquito Repellents for Travellers. BMJ (Clinical Research Ed), 350
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by LSHTM Research Online Stanczyk, NM; Behrens, RH; Chen-Hussey, V; Stewart, SA; Logan, JG (2015) Mosquito repellents for travellers. BMJ (Clinical research ed), 350. h99. ISSN 0959-8138 DOI: 10.1136/bmj.h99 Downloaded from: http://researchonline.lshtm.ac.uk/2121428/ DOI: 10.1136/bmj.h99 Usage Guidelines Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna- tively contact [email protected]. Available under license: Creative Commons Attribution Non-commercial http://creativecommons.org/licenses/by-nc/2.5/ BMJ 2015;350:h99 doi: 10.1136/bmj.h99 (Published 19 February 2015) Page 1 of 4 Practice PRACTICE THERAPEUTICS Mosquito repellents for travellers 1 1 2 Nina M Stanczyk research fellow , Ron H Behrens senior lecturer , Vanessa Chen-Hussey research 1 3 scientist and clinical trials manager , Sophie A Stewart senior research scientist and clinical trials 3 1 3 coordinator , James G Logan senior lecturer 1Department of Disease Control, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; 2Hospital for Tropical Diseases, London, UK; 3Arthropod Control Product Test Centre, London School of Hygiene and Tropical Medicine, London, UK This is one of a series of occasional articles on therapeutics for common isolated as a byproduct of Eucalyptus citriodora (lemon or serious conditions, covering new drugs and old drugs with important eucalyptus). new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham Icaridin—Icaridin (hydroxyethyl isobutyl piperidine and Birmingham City Hospital, and Albert Ferro, professor of carboxylate) is also known by the trade names Bayrepel, cardiovascular clinical pharmacology, King’s College London. -
Reflexion on Bio-Sourced Mosquito Repellents: Nature, Activity, and Preparation Claude Grison, David Carrasco, Franck Pelissier, Alexandra Moderc
Reflexion on Bio-Sourced Mosquito Repellents: Nature, Activity, and Preparation Claude Grison, David Carrasco, Franck Pelissier, Alexandra Moderc To cite this version: Claude Grison, David Carrasco, Franck Pelissier, Alexandra Moderc. Reflexion on Bio-Sourced Mosquito Repellents: Nature, Activity, and Preparation. Frontiers in Ecology and Evolution, Fron- tiers Media S.A, 2020, 8, 10.3389/fevo.2020.00008. hal-03051738 HAL Id: hal-03051738 https://hal.archives-ouvertes.fr/hal-03051738 Submitted on 10 Dec 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License fevo-08-00008 February 5, 2020 Time: 16:18 # 1 REVIEW published: 07 February 2020 doi: 10.3389/fevo.2020.00008 Reflexion on Bio-Sourced Mosquito Repellents: Nature, Activity, and Preparation Claude Grison1*, David Carrasco2, Franck Pelissier1 and Alexandra Moderc1 1 Laboratory of Bio-inspired Chemistry and Ecological Innovations, ChimEco (UMR 5021), University of Montpellier, CNRS, Montpellier, France, 2 MIVEGEC, University of Montpellier, IRD, CNRS, Montpellier, France Over the last decades, the geographical distribution of certain mosquito species carrying vector-borne diseases has considerably expanded. They represent a major health concern as they transmit pathogens causing alarming epidemics. -
Mosquito Repellent Thermal Stability, Permeability and Air Volatility
Published as: António B Mapossa, Walter W Focke, Alcides Sitoe, Homa Izadi, Elizbé du Toit, René Androsch, Chanita Sungkapreecha, L. van der Merwe. Mosquito repellent thermal stability, permeability and air volatility. Pest Management Science, 76, 1112-1120. Mosquito repellent thermal stability, permeability and air volatility António B Mapossa1,2, Alcides Sitoe1,2,3, Walter W Focke1,2,*, Homa Izadi1, Elizabeth L du Toit1, René Androsch4, Chanita Sungkapreecha4, Elizabet M. van der Merwe5 1Institute of Applied Materials, Department of Chemical Engineering, University of Pretoria, Lynnwood Road, Pretoria, South Africa 2UP Institute for Sustainable Malaria Control & MRC Collaborating Centre for Malaria Research, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa, Pretoria, South Africa 3Department of Chemistry, Eduardo Mondlane University, Maputo, Mozambique 4Interdisciplinary Center for Transfer-oriented Research in Natural Sciences, Martin Luther University Halle- Wittenberg, D-06099 Halle/Saale, Germany 5Department of Chemistry, University of Pretoria, Lynnwood Road, Pretoria, South Africa Abstract BACKGROUND: The effectiveness of mosquito repellents, whether applied topically on the skin or released from a wearable device, is crucially determined by the evaporation rate. This is because a repellent has to be present in the form of vapour in the vicinity of the exposed skin that needs protection. Therefore, gravimetric techniques were used to investigate the direct evaporation of selected liquid repellents, their permeation through polymer films, and their release from a microporous polyethylene matrix. RESULTS: Evaporation of a repellent into quiescent air is determined by its air permeability. It is defined as the product of the vapour pressure and the diffusion coefficient, i.e. = . It was found that the repellent ranking, in terms of decreasing volatility, was ethyl anthranilate > citriodiol > dimethyl phthalate > DEET > decanoic acid > ethyl butylacetylaminopropionate > Icaridin. -
Insect Repellent Essentials
Insect Repellent Essentials: A Brief Guide Insect repellents are substances that, when used as directed, can reduce tick, mosquito, and other insect bites. Preventing bites will help you avoid disease-causing pathogens carried by these animals. WHY SHOULD YOU USE INSECT REPELLENT? You can protect yourself from ticks and mosquitoes by properly applying insect repellents when outdoors during times of year when these critters are most active. Repellents used on your skin generally work by How do they making it harder for biting insects and ticks to work? smell or find you. Not all ticks and mosquitoes carry disease-causing agents, but there are a few in the Northeast that can be harmful: Several mosquito species in the Northeast can transmit: West Nile virus Eastern equine encephalitis virus LaCrosse encephalitis virus Jamestown Canyon virus Blacklegged (aka deer) ticks: Lone star ticks: Lyme disease Ehrlichiosis Anaplasmosis Tularemia Babesiosis Heartland virus Ehrlichiosis Powassan virus disease American dog ticks: Brown dog ticks: Tularemia Rocky Mountain Rocky Mountain Spotted Fever Spotted Fever Visit www.cdc.gov/ncezid/dvbd to learn more about these vector-borne diseases WHEN SHOULD YOU APPLY INSECT REPELLENT? Apply insect repellent when you are outdoors in tick or mosquito habitats. Ticks in the Northeast can be active year-round and any time of day. They are most active during the warmer months of the year, and can be as small as poppy seeds during the spring and summer. You can still be bitten by a tick in the winter! If the temperature is warm enough and the snow has started to melt, ticks can be active. -
123. Antimony
1998:11 The Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals 123. Antimony John Erik Berg Knut Skyberg Nordic Council of Ministers arbete och hälsa vetenskaplig skriftserie ISBN 91–7045–471–x ISSN 0346–7821 http://www.niwl.se/ah/ah.htm National Institute for Working Life National Institute for Working Life The National Institute for Working Life is Sweden's center for research and development on labour market, working life and work environment. Diffusion of infor- mation, training and teaching, local development and international collaboration are other important issues for the Institute. The R&D competence will be found in the following areas: Labour market and labour legislation, work organization and production technology, psychosocial working conditions, occupational medicine, allergy, effects on the nervous system, ergonomics, work environment technology and musculoskeletal disorders, chemical hazards and toxicology. A total of about 470 people work at the Institute, around 370 with research and development. The Institute’s staff includes 32 professors and in total 122 persons with a postdoctoral degree. The National Institute for Working Life has a large international collaboration in R&D, including a number of projects within the EC Framework Programme for Research and Technology Development. ARBETE OCH HÄLSA Redaktör: Anders Kjellberg Redaktionskommitté: Anders Colmsjö och Ewa Wigaeus Hjelm © Arbetslivsinstitutet & författarna 1998 Arbetslivsinstitutet, 171 84 Solna, Sverige ISBN 91–7045–471–X ISSN 0346-7821 Tryckt hos CM Gruppen Preface The Nordic Council is an intergovernmental collaborative body for the five countries, Denmark, Finland, Iceland, Norway and Sweden. One of the committees, the Nordic Senior Executive Committee for Occupational Environmental Matters, initiated a project in order to produce criteria documents to be used by the regulatory authorities in the Nordic countries as a scientific basis for the setting of national occupational exposure limits. -
General Pharmacology
GENERAL PHARMACOLOGY Winners of “Nobel” prize for their contribution to pharmacology Year Name Contribution 1923 Frederick Banting Discovery of insulin John McLeod 1939 Gerhard Domagk Discovery of antibacterial effects of prontosil 1945 Sir Alexander Fleming Discovery of penicillin & its purification Ernst Boris Chain Sir Howard Walter Florey 1952 Selman Abraham Waksman Discovery of streptomycin 1982 Sir John R.Vane Discovery of prostaglandins 1999 Alfred G.Gilman Discovery of G proteins & their role in signal transduction in cells Martin Rodbell 1999 Arvid Carlson Discovery that dopamine is neurotransmitter in the brain whose depletion leads to symptoms of Parkinson’s disease Drug nomenclature: i. Chemical name ii. Non-proprietary name iii. Proprietary (Brand) name Source of drugs: Natural – plant /animal derivatives Synthetic/semisynthetic Plant Part Drug obtained Pilocarpus microphyllus Leaflets Pilocarpine Atropa belladonna Atropine Datura stramonium Physostigma venenosum dried, ripe seed Physostigmine Ephedra vulgaris Ephedrine Digitalis lanata Digoxin Strychnos toxifera Curare group of drugs Chondrodendron tomentosum Cannabis indica (Marijuana) Various parts are used ∆9Tetrahydrocannabinol (THC) Bhang - the dried leaves Ganja - the dried female inflorescence Charas- is the dried resinous extract from the flowering tops & leaves Papaver somniferum, P album Poppy seed pod/ Capsule Natural opiates such as morphine, codeine, thebaine Cinchona bark Quinine Vinca rosea periwinkle plant Vinca alkaloids Podophyllum peltatum the mayapple -
Mosquitoes and West Nile Virus
Biologist’s meeting 11-Feb-2016 Scott C. Crans Rutgers Entomology/CVB/OCPE Contact Info: [email protected] Phone 848 932-6497 • Zika update Objectives • Vector bionomics • Species distribution • ID & monitoring • Local MCP response • Trapping • Reference collections CDC Survey https://docs.google.com/forms/d/1eqWDzmFw7AEGDyooZwpUXsebzh8qrUkzQJ82PDiYLPI/viewform?c=0&w=1 Fill out the survey for your county Maps were developed by CDC using currently available information. Mosquito populations may be detected in areas not shaded on this map, and may not be consistently found in all shaded areas. Container ecosystem • Container mosquitoes • Develop in <1L of water Endless examples Primary vector of Yellow fever, Dengue, Chikungunya, Zika http://fmel.ifas.ufl.edu/key/genus/aedes_aeg.shtml • Urban mosquito • Container habitats • Day biting (dusk & dawn) • Multiple bloodmeals • Endophilic • Anthropophilic Aedes aegypti • Highly adaptive mosquito • Natural & artificial containers • Rural & suburban • Opportunistic day biting (dusk & dawn) • Outside & inside • *Wider host range Aedes albopictus 10 d ? 3-7 d ? extrinsic incubation intrinsic incubation gonotrophic cycle ? State & county mosquito control responsibilities IVM components (Integrated Vector Management) • Continuing professional education • Public education • Mosquito & virus surveillance • Source reduction • Bio-Control • Larviciding • Pupiciding • Aduticiding • Annual reporting NJ philosophy • Measures populations • Justifies intervention • Effectiveness of abatement • Targets -
Natural and Synthetic Repellents for Pest Management of the Storage Mite Tyrophagus Putrescentiae (Schrank) (Sarcoptiformes: Acaridae)
insects Article Natural and Synthetic Repellents for Pest Management of the Storage Mite Tyrophagus putrescentiae (Schrank) (Sarcoptiformes: Acaridae) Naomi Manu 1, Mark Wesley Schilling 2 and Thomas Wesley Phillips 1,* 1 Department of Entomology, Kansas State University, Manhattan, KS 66506, USA; [email protected] 2 Department of Food Science Nutrition and Health Promotion, Mississippi State University, Mississippi State, MS 39762, USA; [email protected] * Correspondence: [email protected] Simple Summary: The ham mite is the major pest of dry-cured hams, aged cheeses, and specialty pet foods that are high in fats and proteins. Ham mites are also known to cause allergies in some cases for humans. The toxic fumigant gas methyl bromide had been used for years to control this mite pest, but it is being phased out of use due to its impact on the protective ozone layer of the earth’s upper atmosphere. Ham producers now require alternatives to methyl bromide for controlling mites. We conducted laboratory experiments with food-safe synthetic and plant-derived chemical repellents to keep mites away from dry cured hams. Our results showed that several of these repellents could effectively prevent ham mites from contacting and staying on treated pieces of ham, and that they would readily go to untreated ham pieces when given a choice. Further experiments found that mites would not feed on nor produce offspring when held on ham pieces coated with oils from thyme, lemon grass, rose, or a mixture of naturally occurring fat molecules. Our experiments suggest that Citation: Manu, N.; Schilling, these food-safe repellents might protect dry-cured hams from mites during their time in aging rooms M.W.; Phillips, T.W. -
Key Messages and Actions for Zika Prevention and Control: Guide for Schools Contents
© UNICEF/UN018982/Arcos Key Messages and Actions for Zika Prevention and Control: Guide for Schools Contents Preface 3 Introduction 4 1. Zika virus 6 Zika signs and symptoms 6 Treatment: Zika 6 2. Other Diseases Transmitted by the Aedes Mosquito 8 Chikungunya virus 8 Yellow fever virus 8 Dengue virus 8 Protect yourself and school community members from 10 mosquito bites at school and at home Prevention of mosquito borne viruses 12 3. Key actions for school administrators, teachers, and staff 14 4. Key actions for parents and community members 19 Engagement of Staff and Children 19 5. Age specific Health Education – Zika 20 5–11 years of age 20 12–16 years of age 21 A Zika checklist for students 23 6. Additional resources/tools 24 ANNEX 1 25 Preface On 1 February 2016, the World Health Organization (WHO) determined that the clusters of microcephaly and other neurological disorders constitute a Public Health Emergency of International Concern (PHEIC). WHO has developed a Strategic Response Framework (SRF) and Joint Operations Plan in response to the Zika outbreak. This guide for schools, developed by UNICEF with the support of WHO and the Centers for Disease Control and Prevention (CDC), aims to provide guidance on Zika prevention and control in the school setting to complement the Strategic Response Framework. The target audiences for this document includes Ministries of Education (national, provincial, and district level), school administrators, teachers and students, as well as program managers and policy makers from other organizations supporting education programs and systems. In addition, the guide contains information that can be adapted for students and their parents in the wider school community. -
Chemical Names and CAS Numbers Final
Chemical Abstract Chemical Formula Chemical Name Service (CAS) Number C3H8O 1‐propanol C4H7BrO2 2‐bromobutyric acid 80‐58‐0 GeH3COOH 2‐germaacetic acid C4H10 2‐methylpropane 75‐28‐5 C3H8O 2‐propanol 67‐63‐0 C6H10O3 4‐acetylbutyric acid 448671 C4H7BrO2 4‐bromobutyric acid 2623‐87‐2 CH3CHO acetaldehyde CH3CONH2 acetamide C8H9NO2 acetaminophen 103‐90‐2 − C2H3O2 acetate ion − CH3COO acetate ion C2H4O2 acetic acid 64‐19‐7 CH3COOH acetic acid (CH3)2CO acetone CH3COCl acetyl chloride C2H2 acetylene 74‐86‐2 HCCH acetylene C9H8O4 acetylsalicylic acid 50‐78‐2 H2C(CH)CN acrylonitrile C3H7NO2 Ala C3H7NO2 alanine 56‐41‐7 NaAlSi3O3 albite AlSb aluminium antimonide 25152‐52‐7 AlAs aluminium arsenide 22831‐42‐1 AlBO2 aluminium borate 61279‐70‐7 AlBO aluminium boron oxide 12041‐48‐4 AlBr3 aluminium bromide 7727‐15‐3 AlBr3•6H2O aluminium bromide hexahydrate 2149397 AlCl4Cs aluminium caesium tetrachloride 17992‐03‐9 AlCl3 aluminium chloride (anhydrous) 7446‐70‐0 AlCl3•6H2O aluminium chloride hexahydrate 7784‐13‐6 AlClO aluminium chloride oxide 13596‐11‐7 AlB2 aluminium diboride 12041‐50‐8 AlF2 aluminium difluoride 13569‐23‐8 AlF2O aluminium difluoride oxide 38344‐66‐0 AlB12 aluminium dodecaboride 12041‐54‐2 Al2F6 aluminium fluoride 17949‐86‐9 AlF3 aluminium fluoride 7784‐18‐1 Al(CHO2)3 aluminium formate 7360‐53‐4 1 of 75 Chemical Abstract Chemical Formula Chemical Name Service (CAS) Number Al(OH)3 aluminium hydroxide 21645‐51‐2 Al2I6 aluminium iodide 18898‐35‐6 AlI3 aluminium iodide 7784‐23‐8 AlBr aluminium monobromide 22359‐97‐3 AlCl aluminium monochloride